Literature DB >> 10546017

Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.

G L Pittenger1, R A Malik, N Burcus, A J Boulton, A I Vinik.   

Abstract

OBJECTIVE: Neuropathy is the most common complication of diabetes, and toxic serum factors may contribute to its genesis. RESEARCH DESIGN AND METHODS: We assessed neurotoxicity in the serum of 39 diabetic patients and correlated it with clinical measures of somatic and autonomic nerve fiber damage. Sera were applied to N1E-115 and VSC4.1 neuroblastoma cells in vitro as models of sensory/autonomic (S/A) and motor neurons, respectively. Neurotoxicity was measured as either complete or near-complete cell death (highly toxic), inhibited cell growth (moderately toxic), or normal cell proliferation (nontoxic) compared with pooled human serum controls during culture over 4 days.
RESULTS: There was an inverse correlation between neurotoxicity and vibration perception threshold (P < 0.01). Age (P < 0.02), duration of diabetes (P < 0.02), and HbA1c (P < 0.03) correlated with neurotoxicity, suggesting that glycation may contribute to cytotoxicity in this model. S/A neurotoxicity occurred more frequently in the sera of patients with type 1 (19 of 25) than type 2 (5 of 14) diabetes (P < 0.02). None of the sera from either type 1 or type 2 diabetic patients displayed neurotoxicity on VSC4.1 cells, whereas sera from patients with motor neuropathy were highly toxic.
CONCLUSIONS: These studies indicate that there is a relationship between the specific nerve fiber dysfunction in the patient and the type of neuronal cell killed, not only for diabetic neuropathy but also for known forms of autoimmune neuropathies. Such toxic factors may contribute to diabetic neuropathy by acting in concert with hyperglycemia to damage sensory/autonomic neurons.

Entities:  

Mesh:

Year:  1999        PMID: 10546017     DOI: 10.2337/diacare.22.11.1839

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy.

Authors:  M Tavakoli; A J M Boulton; N Efron; R A Malik
Journal:  Cont Lens Anterior Eye       Date:  2010-09-20       Impact factor: 3.077

2.  Uterine leiomyomata in relation to insulin-like growth factor-I, insulin, and diabetes.

Authors:  Donna D Baird; Greg Travlos; Ralph Wilson; David B Dunson; Michael C Hill; Aimee A D'Aloisio; Stephanie J London; Joel M Schectman
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

Review 3.  Acute glycemic control in diabetics. How sweet is oprimal? Con: Just as sweet as in nondiabetic is better.

Authors:  Moritoki Egi
Journal:  J Intensive Care       Date:  2018-11-06

Review 4.  Corneal Confocal Microscopy as a Quantitative Imaging Biomarker of Diabetic Peripheral Neuropathy: A Review.

Authors:  Eleonora Cosmo; Giulia Midena; Luisa Frizziero; Marisa Bruno; Michela Cecere; Edoardo Midena
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

5.  Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model.

Authors:  Yue Li; Yong Zhang; De-bao Liu; Hai-ying Liu; Wu-gang Hou; Yu-shu Dong
Journal:  Int J Med Sci       Date:  2013-02-20       Impact factor: 3.738

6.  A 41-year-old man with polyarthritis and severe autonomic neuropathy.

Authors:  Matthew E Bourcier; Aaron I Vinik
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.